Join
Live feed
·
PRReleasevia Quantisnow
Heron Therapeutics Inc. logo

Heron Therapeutics Announces U.S. FDA Approval of APONVIE™ (HTX-019) for the Prevention of Postoperative Nausea and Vomiting (PONV)

ByQuantisnow·Wall Street's wire, on your screen.
HRTX· Heron Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HRTX (Heron Therapeutics Inc.) and more on Quantisnow.